TD Cowen Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN) had its target price dropped by research analysts at TD Cowen from $7.00 to $6.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the construction company’s stock. TD Cowen’s price objective would indicate a potential upside of 99.67% from the stock’s previous close.

Several other equities analysts have also commented on ASPN. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Barclays reduced their price target on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Finally, Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $4.50.

Aspen Aerogels Trading Up 16.9%

Shares of NYSE:ASPN traded up $0.44 during trading on Thursday, reaching $3.01. 1,292,704 shares of the company were exchanged, compared to its average volume of 1,573,191. The business’s fifty day simple moving average is $3.31 and its 200-day simple moving average is $5.08. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. Aspen Aerogels has a 12-month low of $2.30 and a 12-month high of $9.78. The firm has a market capitalization of $248.36 million, a PE ratio of -0.81 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.07). The firm had revenue of $41.34 million during the quarter, compared to the consensus estimate of $44.25 million. Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.The firm’s revenue for the quarter was down 66.4% compared to the same quarter last year. During the same period last year, the company earned $0.14 EPS. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, research analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current year.

Institutional Trading of Aspen Aerogels

Institutional investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC increased its position in Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock valued at $28,000 after buying an additional 4,390 shares in the last quarter. Balance Wealth LLC acquired a new position in shares of Aspen Aerogels during the fourth quarter valued at about $29,000. Drive Wealth Management LLC purchased a new position in shares of Aspen Aerogels in the 4th quarter valued at approximately $30,000. Jefferson Bridge Capital LLC acquired a new stake in Aspen Aerogels in the 4th quarter worth approximately $32,000. Finally, SBI Securities Co. Ltd. boosted its stake in Aspen Aerogels by 67.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after purchasing an additional 2,551 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

More Aspen Aerogels News

Here are the key news stories impacting Aspen Aerogels this week:

• Positive Sentiment: Firm balance sheet and near-term cash boost — Aspen closed 2025 with $158.6M cash and expects a ~$37.6M GM commercial settlement in Q1 2026, which supports near-term liquidity and funds the strategic review. GlobeNewswire: Q4 & Full Year 2025 Results
• Positive Sentiment: Strategic review initiated — management engaged Piper Sandler to evaluate options (capital-structure optimization, asset sales, other actions) that could create shareholder value. The review gives the company flexibility to pursue transactions that might unlock value. GlobeNewswire: Strategic Review Announcement
• Positive Sentiment: Commercial momentum — Aspen highlighted a North Sea subsea pipeline award and expansion of European OEM relationships (e.g., Volvo), indicating continued project wins outside North America. GlobeNewswire: Commercial Developments
• Neutral Sentiment: Full earnings call/transcript coverage is available (management commentary expands on causes of the revenue decline, cost actions and outlook). Read the call transcript for Q&A details that could affect near‑term guidance interpretation. Seeking Alpha: Q4 2025 Earnings Call Transcript
• Negative Sentiment: Sharp revenue and GAAP profit deterioration — Q4 revenue fell to $41.3M (‑66% Y/Y) and the company reported a GAAP net loss of $72.9M (EPS ‑$0.88). Full‑year revenue dropped to $271.1M and included a $291.2M impairment tied to the Statesboro plant. These headline misses weigh on near‑term fundamentals. GlobeNewswire: Q4 & Full Year 2025 Results
• Negative Sentiment: Below‑consensus Q1 2026 guidance — Aspen issued Q1 revenue guidance of $35–$40M and EPS guidance of ‑$0.28 to ‑$0.24 (below consensus), signaling continued softness in thermal‑barrier (EV) volumes and an expected net loss in Q1. GlobeNewswire: Q1 2026 Outlook
• Negative Sentiment: Potential litigation risk — plaintiff firm Johnson Fistel announced an investigation into potential claims involving Aspen’s executives, which could lead to legal costs or distraction. GlobeNewswire: Johnson Fistel Investigation Notice

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.